Clinical/biochemical characteristics and related outcomes in people with new-onset diabetes and COVID-19: experience from a single centre

被引:5
作者
Munoz Moreno, Diego [1 ]
Anez Ramos, Roberto Jose [1 ]
Gonzalez Fernandez, Laura [1 ]
Rivas Montenegro, Alejandra Maricel [1 ]
Miguelez Gonzalez, Maria [2 ]
Brox Torrecilla, Noemi [3 ]
Gonzalez Albarran, Olga [1 ]
机构
[1] Gen Univ Gregorio Maranon Hosp, Endocrinol & Nutr Dept, Madrid 28009, Spain
[2] Fdn Jimenez Diaz, Endocrinol & Nutr Dept, Madrid, Spain
[3] Univ Hosp Ramon y Cajal, Endocrinol & Nutr Dept, Madrid, Spain
关键词
new-onset diabetes mellitus; COVID-19; SARS-CoV-2; hospital admission;
D O I
10.1002/pdi.2426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: It is known that there is a bidirectional relationship between diabetes mellitus (DM) and coronavirus disease (COVID-19). It has been described that those patients infected with SARS-CoV-2 could develop severe metabolic decompensation of pre-existing or new-onset DM, although diabetogenic effect of SARS-CoV-2 has still not been well consolidated. In fact, the coexistence of SARS-CoV-2 infection and new-onset DM is an infrequent situation. Methods: We describe the clinical and analytical characteristics of 19 patients admitted to a Spanish tertiary hospital - all 19 having COVID-19 infection and new-onset DM. Results: 12/19 patients (63.2%) were female; the mean age at diagnosis of DM was 54 (39-65) years. The most frequent ethnic group was Caucasian (n=9), followed by Latin-American (n=7); 7/19 (36.8%) previously met criteria for prediabetes due to altered basal glycaemia or HbA(1c). The mean BMI at diagnosis was 32.26kg/m(2) (27.62-35.18kg/m(2)). Eighteen of 19 patients (94.7%) showed bilateral bronchopneumonia. The mean blood glucose of the first blood was 17.5mmol/L (11.1-21.1mmol/L), and the mean HbA(1c) was 88mmol/mol (60-115mmol/mol). C-peptide was requested in eight patients and it was within normal range in 87.5% (n=7) and below the inferior threshold in one case. Autoantibodies were requested in 26.3% (five patients), being negative in 4/5 (80%) and positive in 1/5 (20%). Regarding the type of diabetes diagnosed, 18 were type 2 DM and only one case was diagnosed with type 1 DM. Seventeen had simple hyperglycaemia and two suffered a diabetic ketoacidosis. The mean HbA(1c) at 8.0 months (5.0-12.0 months) follow-up was 42mmol/mol (40-49mmol/mol). Conclusion: The majority of those described had type 2 DM that appears to have been unmasked by the COVID-19 infection, since they had high HbA(1c) and several risk factors for diabetes development, such as obesity and prediabetes. Most of them had their pancreatic reserve preserved, and this may suggest insulin resistance as the aetiology rather than direct beta-cell damage. A good evolution of diabetes after hospital discharge was observed in the patients followed up at our centre. Copyright (c) 2022 John Wiley & Sons.
引用
收藏
页码:24 / 31
页数:8
相关论文
共 33 条
  • [1] 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022
    American Diabetes Association Professional Practice Committee
    [J]. DIABETES CARE, 2022, 45 : S17 - S38
  • [2] Effects of COVID-19 Home Confinement on Eating Behaviour and Physical Activity: Results of the ECLB-COVID19 International Online Survey
    Ammar, Achraf
    Brach, Michael
    Trabelsi, Khaled
    Chtourou, Hamdi
    Boukhris, Omar
    Masmoudi, Liwa
    Bouaziz, Bassem
    Bentlage, Ellen
    How, Daniella
    Ahmed, Mona
    Mueller, Patrick
    Mueller, Notger
    Aloui, Asma
    Hammouda, Omar
    Paineiras-Domingos, Laisa Liane
    Braakman-Jansen, Annemarie
    Wrede, Christian
    Bastoni, Sofia
    Pernambuco, Carlos Soares
    Mataruna, Leonardo
    Taheri, Morteza
    Irandoust, Khadijeh
    Khacharem, Aimen
    Bragazzi, Nicola L.
    Chamari, Karim
    Glenn, Jordan M.
    Bott, Nicholas T.
    Gargouri, Faiez
    Chaari, Lotfi
    Batatia, Hadj
    Ali, Gamal Mohamed
    Abdelkarim, Osama
    Jarraya, Mohamed
    El Abed, Kais
    Souissi, Nizar
    Van Gemert-Pijnen, Lisette
    Riemann, Bryan L.
    Riemann, Laurel
    Moalla, Wassim
    Gomez-Raja, Jonathan
    Epstein, Monique
    Sanderman, Robbert
    Schulz, Sebastian V. W.
    Jerg, Achim
    Al-Horani, Ramzi
    Mansi, Taiysir
    Jmail, Mohamed
    Barbosa, Fernando
    Ferreira-Santos, Fernando
    Simunic, Bostjan
    [J]. NUTRIENTS, 2020, 12 (06)
  • [3] Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management
    Anka, Abubakar Umar
    Tahir, Mohammed Ibrahim
    Abubakar, Sharafudeen Dahiru
    Alsabbagh, Mohamed
    Zian, Zeineb
    Hamedifar, Haleh
    Sabzevari, Araz
    Azizi, Gholamreza
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 93 (04)
  • [4] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
    Arabi, Yaseen M.
    Gordon, Anthony C.
    Derde, Lennie P. G.
    Nichol, Alistair D.
    Murthy, Srinivas
    Al Beidh, Farah
    Annane, Djillali
    Al Swaidan, Lolowa
    Beane, Abi
    Beasley, Richard
    Berry, Lindsay R.
    Bhimani, Zahra
    Bonten, Marc J. M.
    Bradbury, Charlotte A.
    Brunkhorst, Frank M.
    Buxton, Meredith
    Buzgau, Adrian
    Cheng, Allen
    De Jong, Menno
    Detry, Michelle A.
    Duffy, Eamon J.
    Estcourt, Lise J.
    Fitzgerald, Mark
    Fowler, Rob
    Girard, Timothy D.
    Goligher, Ewan C.
    Goossens, Herman
    Haniffa, Rashan
    Higgins, Alisa M.
    Hills, Thomas E.
    Horvat, Christopher M.
    Huang, David T.
    King, Andrew J.
    Lamontagne, Francois
    Lawler, Patrick R.
    Lewis, Roger
    Linstrum, Kelsey
    Litton, Edward
    Lorenzi, Elizabeth
    Malakouti, Salim
    McAuley, Daniel F.
    McGlothlin, Anna
    Mcguinness, Shay
    McVerry, Bryan J.
    Montgomery, Stephanie K.
    Morpeth, Susan C.
    Mouncey, Paul R.
    Orr, Katrina
    Parke, Rachael
    Parker, Jane C.
    [J]. INTENSIVE CARE MEDICINE, 2021, 47 (08) : 867 - 886
  • [5] The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis
    Bassatne, Aya
    Basbous, Maya
    Chakhtoura, Marlene
    El Zein, Ola
    Rahme, Maya
    Fuleihan, Ghada El-Hajj
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 119
  • [6] New onset diabetes, type 1 diabetes and COVID-19
    Boddu, Sirisha Kusuma
    Aurangabadkar, Geeta
    Kuchay, Mohammad Shafi
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (06) : 2211 - 2217
  • [7] Practical recommendations for the management of diabetes in patients with COVID-19
    Bornstein, Stefan R.
    Rubino, Francesco
    Khunti, Kamlesh
    Mingrone, Geltrude
    Hopkins, David
    Birkenfeld, Andreas L.
    Boehm, Bernhard
    Amiel, Stephanie
    Holt, Richard I. G.
    Skyler, Jay S.
    DeVries, J. Hans
    Renard, Eric
    Eckel, Robert H.
    Zimmet, Paul
    George Alberti, Kurt
    Vidal, Josep
    Geloneze, Bruno
    Chan, Juliana C.
    Ji, Linong
    Ludwig, Barbara
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (06) : 546 - 550
  • [8] Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus
    Chee, Ying Jie
    Ng, Shereen Jia Huey
    Yeoh, Ester
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 164
  • [9] American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
    Cuker, Adam
    Tseng, Eric K.
    Nieuwlaat, Robby
    Angchaisuksiri, Pantep
    Blair, Clifton
    Dane, Kathryn
    Davila, Jennifer
    DeSancho, Maria T.
    Diuguid, David
    Griffin, Daniel O.
    Kahn, Susan R.
    Klok, Frederikus A.
    Lee, Alfred Ian
    Neumann, Ignacio
    Pai, Ashok
    Pai, Menaka
    Righini, Marc
    Sanfilippo, Kristen M.
    Siegal, Deborah
    Skara, Mike
    Touri, Kamshad
    Akl, Elie A.
    Akl, Imad Bou
    Boulos, Mary
    Brignardello-Petersen, Romina
    Charide, Rana
    Chan, Matthew
    Dearness, Karin
    Darzi, Andrea J.
    Kolb, Philipp
    Colunga-Lozano, Luis E.
    Mansour, Razan
    Morgano, Gian Paolo
    Morsi, Rami Z.
    Noori, Atefeh
    Piggott, Thomas
    Qiu, Yuan
    Roldan, Yetiani
    Schuenemann, Finn
    Stevens, Adrienne
    Solo, Karla
    Ventresca, Matthew
    Wiercioch, Wojtek
    Mustafa, Reem A.
    Schuenemann, Holger J.
    [J]. BLOOD ADVANCES, 2021, 5 (03) : 872 - 888
  • [10] Glucocorticoids and beta-cell function
    Fichna, Marta
    Fichna, Piotr
    [J]. ENDOKRYNOLOGIA POLSKA, 2017, 68 (05) : 568 - 573